Med BioGene Inc
Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. Many Bright Ideas Technologies Inc. is headquartered in Vancouver, Canad… Read more
Market Cap & Net Worth: Med BioGene Inc (MBGNF)
Med BioGene Inc (PINK:MBGNF) has a market capitalization of $172.58K ($172.58K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #41154 globally and #13383 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Med BioGene Inc's stock price $0.01 by its total outstanding shares 17257838 (17.26 Million).
Med BioGene Inc Market Cap History: 2015 to 2025
Med BioGene Inc's market capitalization history from 2015 to 2025. Data shows change from $11.39 Million to $172.58K (-32.97% CAGR).
Med BioGene Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Med BioGene Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MBGNF by Market Capitalization
Companies near Med BioGene Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Med BioGene Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #93 globally with a market cap of $174.19 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #150 globally with a market cap of $120.45 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #468 globally with a market cap of $45.61 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #507 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #93 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.19 Billion | $464.69 |
| #150 | Danaher Corporation | NYSE:DHR | $120.45 Billion | $191.50 |
| #468 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.61 Billion | $577.12 |
| #507 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Med BioGene Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Med BioGene Inc's market cap moved from $11.39 Million to $ 172.58K, with a yearly change of -32.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $172.58K | 0.00% |
| 2024 | $172.58K | 0.00% |
| 2023 | $172.58K | -90.55% |
| 2022 | $1.83 Million | -3.82% |
| 2021 | $1.90 Million | +175.00% |
| 2020 | $690.31K | +33.78% |
| 2019 | $516.01K | +69.89% |
| 2018 | $303.74K | -82.40% |
| 2017 | $1.73 Million | -59.84% |
| 2016 | $4.30 Million | -62.27% |
| 2015 | $11.39 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Med BioGene Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $172.58K USD |
| MoneyControl | $172.58K USD |
| MarketWatch | $172.58K USD |
| marketcap.company | $172.58K USD |
| Reuters | $172.58K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.